2011-2012 Influenza Season: Antiviral Medication Recommendations

Presenter(s)

Overview

CDC estimates that influenza virus infections in the United States result in an average of more than 200,000 related hospitalizations, and between 3,300 to 49,000 deaths each year, depending upon the severity of the influenza season. Annual influenza vaccination is recommended for all persons aged 6 months and older, and is the best way to prevent influenza. However, available evidence consistently indicates that antiviral treatment, when initiated as early as possible in patients with confirmed or suspected influenza, can reduce severe outcomes of influenza. During this COCA conference call, a subject matter expert will review current Advisory Committee on Immunization Practices (ACIP) and CDC guidance on the use of antiviral medications in the prevention and treatment of influenza.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• List currently recommended influenza antiviral medications
• Understand recommendations for use of influenza antiviral medications for the 2011-2012 influenza season
• Understand the potential benefits of antiviral treatment as outlined by the Advisory Committee on Immunization Practices (ACIP) and CDC

Call Materials

• Slides:View Now
• Webcast:Watch Now
• Audio:Listen Now
• Transcript:Read Now

Additional Resources

• CDC 2011-2012 Influenza Antiviral Medications: A Summary for Clinicians
• CDC Online Newsroom "Have You Heard?" CDC Recommendations for Influenza Antiviral Medications Remain Unchanged
• Morbidity and Mortality Weekly Report: Recommendations and Reports - Jan 21, 2011 / 60(RR01);1-28 Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Call Format

• Live webcast and audio conference call on 2/28/12: 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 2/28/12
• Materials: PowerPoint slide set

Additional Call information